Drug profile · INN
corticotropin-zinc hydroxide
CORTROPHIN-ZINC
corticotropin-zinc hydroxide (CORTROPHIN-ZINC) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — corticotropin-zinc hydroxide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
corticotropin-zinc hydroxide (CORTROPHIN-ZINC) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Melanocortin receptor 2 agonist
Primary target: Adrenocorticotropic hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is corticotropin-zinc hydroxide?
corticotropin-zinc hydroxide (CORTROPHIN-ZINC) is a melanocortin receptor 2 agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for corticotropin-zinc hydroxide?
CORTROPHIN-ZINC is a marketed brand name for corticotropin-zinc hydroxide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of corticotropin-zinc hydroxide?
corticotropin-zinc hydroxide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.